The current understanding and management of vaccine-associated sarcomas in cats

Journal of the American Veterinary Medical Association

Volumn 226, Issue 11, 2005, Pages 1821-1842

  Richards, James R ^a   Starr, Robin M ^b   Childers, Henry E ^c   Elston, Thomas H ^d   Hendrick, Mattie J ^e   Kitchell, Barbara E ^f   Macy, Dennis W ^g   McClure, Kent D ^h   Morrison, Wallace B ⁱ   Vogel, Lyle P ^j   Welborn, Link V ^c   Brunt, Jane E ^k   Glickman, Larry T ⁱ   Kass, Philip H ^l   McEntee, Margaret C ^a   McGill, Lawrence D ^m   Schultz, Ronald D ⁿ  

^a Department of Obstetrics Gynecology   (United States)

^b Freedom Service Dogs Inc   (United States)

^c Cat Hospital ^*  (United States)

^d Cat Hospital of Irvine   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

^g Department of Environmental and Radiological Health Sciences   (United States)

^h Animal Health Institute   (United States)

ⁱ PURDUE UNIVERSITY   (United States)

^j American Veterinary Medical Association   (United States)

^k Cat Hospital at Towson   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m ARUP LABORATORIES   (United States)

ⁿ UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FELINE LEUKEMIA VIRUS VACCINE; HERPES VACCINE; IFOSFAMIDE; LONG ACTING DRUG; LUFENURON; METHYLPREDNISOLONE ACETATE; MITOXANTRONE; PENICILLIN G; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; RABIES VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; BONE MARROW SUPPRESSION; CALICIVIRUS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CAT DISEASE; CHEMOSENSITIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG INDUSTRY; EXCISION; FELINE PANLEUKOPENIA VIRUS; FEMALE; FERRET; FIBROSARCOMA; GENE OVEREXPRESSION; GEOGRAPHIC DISTRIBUTION; GIARDIA; GLOMERULUS FILTRATION RATE; GOVERNMENT; HISTOPATHOLOGY; INBRED STRAIN; INJECTION SITE REACTION; LIPOSARCOMA; LOCAL ANESTHESIA; LYMPHOSARCOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MEDICAL SOCIETY; MOUSE; NEUTROPENIA; NONHUMAN; NORTH AMERICA; OSTEOSARCOMA; RABIES VIRUS; REVACCINATION; RHABDOMYOSARCOMA; RISK REDUCTION; ROUS SARCOMA ONCOVIRUS; SARCOMA; SARCOMA CELL; SURVIVAL TIME; SYMPOSIUM; TUMOR BIOPSY; UNITED STATES; VACCINATION REACTION; VETERINARY MEDICINE;

ANIMALS; CAT DISEASES; CATS; INCIDENCE; RESEARCH; SARCOMA; SOFT TISSUE NEOPLASMS; UNITED STATES; VACCINATION; VETERINARY MEDICINE;

ANIMALIA; CALICIVIRIDAE; CANIS FAMILIARIS; FELIDAE; FELINE LEUKEMIA VIRUS; FELINE PANLEUKOPENIA VIRUS; FELIS CATUS; GIARDIA; GLOMERULUS; HERPES; MUSTELA PUTORIUS FURO; ONCOVIRINAE; RABIES VIRUS; ROUS SARCOMA VIRUS;

EID: 21144470155     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.226.1821     Document Type: Conference Paper

References (66)

1. AVMA Web site. Vaccine-Associated Feline Sarcoma Task Force. Available at: www.avma.org/vafstf. Accessed Apr 18, 2005.
2. AVMA Web site. Vaccine-Associated Feline Sarcoma Task Force. Vaccines and sarcomas: a concern for cat owners. Available at: www.avma.org/vafstf/ownbroch. asp. Accessed Apr 18, 2005.
3. AVMA Web site. Vaccine-Associated Feline Sarcoma Task Force. VAFSTF selected bibliographic references. Available at: www.avma.org/vafstf/bibrefs. asp. Accessed Apr 18, 2005.
4. Hendrick MJ, Bergman PJ, Couto CG, et al. Vaccine-associated feline sarcoma symposium. J Am Vet Med Assoc 1998;213: 1422-1430.
5. McEntee MC. Treatment decision making for cats with vaccine-associated sarcomas, Part I and II. In: Convention notes of the J38th Annual Convention of the American Veterinary Medical Association. Schaumburg, Ill: American Veterinary Medical Association, 2001;447-448.
6. Borjesson D, Madewell BR, McEntee MC, et al. Feline vaccine-associated fibrosarcomas. Vet Cancer Soc Newsl 1999;23: 1-11.
7. Morrison WB, Starr RM. Vaccine-associated feline sarcomas. J Am Vet Med Assoc 2001;218:697-702.
8. Kass PH, Barnes WG, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and librosarcoma tumorigenesis in eats. J Am Vet Med Assoc 1993;203:396-405.
9. Kass PH, Spangler WL, Hendrick MJ, et al. Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 2003;223: 1283-1292.
10. Hendrick MJ, Goldschmidt MH, Shofer FS, et al. Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Res 1992;52: 5391-5394.
11. Hill AB. The environment and disease: association or causation, in Proceedings. Royal Soc Med 1965;58:295-300.
12. Esplin DG, Mcgill LD, Meininger AC, et al. Postvaccination sarcomas in cats. J Am Vet Med Assoc 1993;202:1245-1247.
13. Esplin DG. Widespread metastastisis of a fibrosarcoma associated with a vaccination site in a cat. Feline Pract 1995;23(1):13-16.
14. Esplin DG. Metastasizing liposarcoma associated with a vaccination site in a cat. Feline Pract 1996;24(5):20-23.
15. Lester S, Clemett T, Burt A. Vaccine site-associated sarcomas in cats: clinical experience and laboratory review (1982-1993). J Am Anim Hosp Assoc 1996;32:91-95.
16. Rudmann DG, Van Alstine WG, Doddy F, et al. Pulmonary and mediastinal metastases of a vaccination-site sarcoma in a cat. Vet Pathol 1996;33:466-469.
17. Sandler I, Teeger M, Best S. Metastatic vaccine associated fibrosarcoma in a 10-year-old cat. Can Vet J 1997;38:374.
18. Munday JS, Stedman NL, Richey LJ. Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas. Vet Pathol 2003;40:288-293.
19. Vascellari M, Melchiotti E, Bozza MA, et al. Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. J Vet Med A Physiol Pathol Clin Med 2003;50:286-291.
20. Esplin DG, Mcgill LD. Fibrosarcoma at the site of lufenuron injection in a cat. Vet Cancer Soc Newsl 1999;23:8-9.
21. Martins-Green M, Boudreau N, Bissell MJ. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res 1994;54: 4334-4341.
22. Erlewein DL. Post-vaccinal rabies in a cat. Feline Pract 1981;11(2):16-21.
23. Esh JB, Cunningham JG, Wiktor TJ. Vaccine-induced rabies in four cats. J Am Vet Med Assoc 1982;180:1336-1339.
24. Bellinger DA, Chang J, Bunn TO, et al. Rabies induced in a cat by high-egg-passage Flury strain vaccine. J Am Vet Med Assoc 1983;183:997-998.
25. Coyne MJ, Reeves NCR Rosen DK. Estimated prevalence of injection-site sarcomas in cats during 1992. J Am Vet Med Assoc 1997;210:249-251.
26. Gobar GM, Kass PH. World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J Am Vet Med Assoc 2002;220:1477-1482.
27. Doddy FD, Glickman LT, Glickman NW, et al. Feline fibrosarcomas at vaccination sites and non-vaccination sites. J Comp Pathol 1996;114:165-174.
28. Richards JR, Rodan I, Elston T, et al. 2000 Report of the American Association of Feline Practitioners and Academy of Feline Medicine Advisory Panel on Feline Vaccines. Available at: www.aafponline.org/pdf/ guidelines_vaccine.pdf. Accessed Apr 18, 2005.
29. Zeiss CJ, Johnson EM, Dubielzig RR. Feline intraocular tumors may arise from transformation of lens epithelium. Vet Pathol 2003;40:355-362.
30. Carew JS, Schmidt JA, Humphrey SA, et al. Growth factor expression and vaccine-associated sarcoma tumorigenicity, in Proceedings. 19th Annu Vet Cancer Soc Conf 1999;11-13.
31. Katayama R, Huelsmeyer MK, Marr AK, et al. Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma. Cancer Chemother Pharmacol 2004;54:25-33.
32. Massague J. The TGF-beta family of growth and differentiation factors. Cell 1987;49:437-438.
33. Silingardi P, Klein JL, Mesnil M, et al. Growth suppression of transformed BALB/c 3T3 cells by transforming growth factor beta 1 occurs only in the presence of their normal counterparts. Carcinogenesis 1994;15:1181-1185.
34. Turner FC. Sarcomas at sites of subcutaneously implanted Bakelite disks in rats. J Natl Cancer Inst 1941;2:81-83.
35. Brand KG, Johnson KH, Buoen LC. Foreign body tumorigenesis. CRC Crit Rev Toxicol 1976;4:353-394.
36. Smibaldi K, Rosen H, Liu S, et al. Tumors associated with metallic implants in animals. Clin Orthop Relat Res 1976;118: 257-266.
37. Macy DW. The potential role and mechanisms of FeLV vaccine-induced neoplasms. Semin Vet Med Surg (Small Anim) 1995;10:234-237.
38. Macy DW Vaccine adjuvants. Semin Vet Med Surg (Small Anim) 1997;12:206-211.
39. Macy DW, Chretin J. Local postvaccinal reactions of a recombinant rabies vaccine. Vet Forum 1999;16:44-49.
40. Jelinek F. Postinflammatory sarcoma in cats. Exp Toxicol Pathol 2003;55:167-172.
41. Nieto A, Sánchez A, Martinez E, et al. Immunohistochemical expression of p53, fibroblast growth factor-β, and transforming growth factor-α in feline vaccine-associated sarcomas. Vet Pathol 2003;40:651-658.
42. Burton G, Mason KV. Do postvaccinal sarcomas occur in Australian eats? Aust Vet J 1997;75:102-106.
43. Hershey AE, Sorenmo KU, Hendrick MJ, et al. Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996). J Am Vet Med Assoc 2000;216:58-61.
44. Carroll CE, Dubielzig RR, Schultz RD. Cats differ from mink and ferrets in their response to commercial vaccines: a histologic comparison of early vaccine reactions. Vet Pathol 2002;39: 216-227.
45. Hennings H, Devor D, Wenk ML, et al. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethybenz(a)-anthracene or N-methyl-N′-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice: effects of tumor promoters and steriodal anti-inflammatory agents on skin of newborn mice in vivo and in vitro. Cancer Res 1981;41:773-779.
46. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Huntingt) 2002;16:217-226, 219; discussion 230-232.
47. AVMA Web site. Vaccine-Associated Feline Sarcoma Task Force. Vaccine-Associated Feline Sarcoma Task Force guidelines: diagnosis and management of suspected sarcomas. Available at: www.avma.org/vafstf/ tfguidelines99.asp. Accessed Apr 12, 2005.
48. Davidson EB, Gregory CR, Kass PH. Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg 1997;26:265-269.
49. Kuntz CA. Sarcoma surgery technique dehated [lett]. Veterinary Practice News 2001;13(11):5.
50. Hendrick MJ, Shofer FS, Goldschmidt MH, et al. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J Am Vet Med Assoc 1994;205:1425-1429.
51. Barber LG, Sorenmo KU, Cronin KL, et al. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. J Am Anim Hosp Assoc 2000;36:416-421.
52. Jeglum KA, deGuzman E, Young KM. Chemotherapy of advanced mammary adcnocarcinoma in 14 cats. J Am Vet Med Assoc 1985;187:157-160.
53. Poirier VJ, Thamin DH, Kurzman ID, et al. Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats. J Vet Intern Med 2002;16: 726-731.
54. Cronin K, Page RL, Spodnick G, et al. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 1998;39:51-56.
55. Kobayashi T, Hauck ML, Dodge R, et al. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Radiol Ultrasound 2002;43:473-479.
56. Bregazzi VS, LaRue SM, McNiel E, et al. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000). J Am Vet Med Assoc 2001;218:547-550.
57. Cohen M, Wright JC, Brawner WR, et al. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996-2000). J Am Vet Med Assoc 2001;219:1582-1589.
58. Bailey DB, Rassnick KM, Erb HN, et al. Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors. Am J Vet Res 2004;65:1502-1507.
59. Williams LE, Banerji N, Klausner JS, et al. Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. Am J Vet Res 2001;62:1354-1357.
60. Banerji N, Li X, Klausner JS, et al. Evaluation of in vitro chemosensitivity of vaccine-associated feline sarcoma cell lines to vincristine and paclitaxel. Am J Vet Res 2002;63:728-732.
61. Matteucci ML, Anyarambhatla G, Rosner G, et al. Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000;6:3748-3755.
62. Ray-Coquard I, Ranchere-Vince D, Thiesse P, et al. Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses. Eur J Cancer 2003;39: 2021-2025.
63. McLeod DA, Thrall DE. The combination of surgery and radiation in the treatment of cancer: a review. Vet Surg 1989;18:1-6.
64. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomized trial. Lancet 2002;359:2235-2241.
65. Zagars GK, Ballo MT, Pisters PWT, et al. Preoperative versus postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys 2003;56:482-488.
66. Roko JL, Hardy WD. Feline leukemia virus and other retroviruses. In: Sherding R, ed. The cat: diseases and clinical management. New York: Churchill-Livingston, 1994;263-432.